Cell Rep
- KIM M, Vuong HE
Indole-AhR signaling shapes emotional regulation.
Cell Rep. 2026;45:117747.
FASEB J
- DICHTER J
Bile Acid Metabolism as a Unifying Readout for Diet, Microbiome Function, and
Gastrointestinal Disease.
FASEB J. 2026;40:e72273.
Front Med (Lausanne)
- LIU N, Huang Y, Wang Y, Qiao H, et al
Pathogenesis and therapeutic strategies for irritable bowel syndrome: an
integrated perspective from dynamic balance theory of Chinese medicine.
Front Med (Lausanne). 2026;13:1823683.
- JIA Z, Gu X
Initiating multi-strain probiotics is associated with clinically meaningful
symptom relief, better quality of life, and fewer treatment escalations in
IBS-D/IBS-M: a Chinese real-world propensity-matched cohort study.
Front Med (Lausanne). 2026;13:1900112.
Front Public Health
- AN L, Luan M, Yang Y, Wang S, et al
The algorithmic epistemic inversion in gastroenterology: how social media and
psychological vulnerability fuel secondary risks in IBD and IBS management.
Front Public Health. 2026;14:1871219.
Gastroenterology
- BALSIGER LM, Schol J, Raymenants K, Van de Bruaene C, et al
Individualized targeted exclusion diet based on confocal laser endomicroscopy
does not improve irritable bowel syndrome symptoms: a randomized controlled
crossover trial.
Gastroenterology. 2026 Sep 1:S0016-5085(26)07228.
Gut Microbes
- ZHANG Z, Holton M, Ferrer DM, Tripp AD, et al
Metagenome-scale modeling to assess microbiome metabolic complementarity for
precision microbiota transplantation therapies.
Gut Microbes. 2026;18:2725403.
J Dual Diagn
- JO D, Farahmand Y, Friedman K, Shepherd JM, et al
Relationships Between Risky Substance Use and Irritable Bowel Syndrome (IBS)
Severity, Mental Health, and Smoking-Related Processes in Adults with IBS Who
Smoke.
J Dual Diagn. 2026 Sep 1:1-13. doi: 10.1080/15504263.2026.2726789.
J Ethnopharmacol
- XU Y, Wu W, Zhang Z, Dong Y, et al
Si-Si-Gu-Ben granules alleviate diarrhea-predominant irritable bowel syndrome by
modulating gut microbiota and suppressing the TLR4/NF-kappaB pathway: A combined
clinical and animal study.
J Ethnopharmacol. 2026 Sep 4:122352. doi: 10.1016/j.jep.2026.122352.
Neurogastroenterol Motil
- KHALIL C, Suchak KK, Amaro IF, Krut Z, et al
Patients' Real-World Experiences With Pharmacologic Therapies for Irritable Bowel
Syndrome With Constipation: A Mixed-Methods Analysis and Classification of Social
Media and E-Forum Posts.
Neurogastroenterol Motil. 2026;38:e70432.
- SUN X, Lin Q, Xu Y, Hu P, et al
Ameliorating Effects and Autonomic Mechanisms of Transcutaneous Auricular Vagus
Nerve Stimulation on Abdominal Pain in Patients With Functional Dyspepsia and
Irritable Bowel Syndrome.
Neurogastroenterol Motil. 2026;38:e70224.
Ther Adv Gastroenterol
- QIU YN, Zhong BH, Zhang HH, Dai SX, et al
Dynamic precision therapy in chronic gastrointestinal diseases: A focus on
gastroesophageal reflux disease and inflammatory bowel disease-A narrative review
and conceptual perspective.
Ther Adv Gastroenterol. 2026;19:17562848261483778.
United European Gastroenterol J
- GROEN SR, Vork L, Weerts ZZRM, Mujagic Z, et al
Phenotyping Increased Urge to Defecate in Irritable Bowel Syndrome: Analysis of
Symptom, Sensory, and Psychological Profiles.
United European Gastroenterol J. 2026;14:e70287.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016